Kypha discovers, develops and commercializes innovative in-vitro diagnostic biomarker tests within the inflammation and autoimmune space.

For more information, visit Kypha or follow their updates on:



  • $18.9m

Kypha Articles

St. Louis Startup Roadshow to Boston

19 STL Startups in Boston for STL Roadshow: Here’s What Happened on Day 1

Kypha Closes on $3.5 Million Funding Led

Founder of Kypha Awarded 2013’s St. Louis Entrepreneur of the Year